TY - JOUR
T1 - Does statin use affect the risk of developing prostate cancer?
AU - Platz, Elizabeth A.
N1 - Funding Information:
Dr Platz is supported in part by Public Health Service research grant P50 CA58236 from the National Cancer Institute, NIH, Department of Health and Human Services. The content is solely the responsibility of the author and does not necessarily represent the official view of the National Cancer Institute or the NIH.
PY - 2009
Y1 - 2009
N2 - This commentary discusses the findings of Agalliu and colleagues, who performed a population-based, case-control study on the association between statin drugs and prostate cancer risk. Consistent with recent studies, statins were not associated with overall prostate cancer risk, but users had a possible lower risk of advanced disease. Obese men taking a statin had a higher risk of prostate cancer than those not taking a statin; however, a previously conducted, large, prospective, cohort study did not observe this association. This unexpected finding by Agalliu et al. could be a chance result, or could have arisen because of complex bias. Although statins might favorably affect men's prostate health, evidence is too limited to recommend statin use for the prevention of advanced prostate cancer. Consideration of the harms and benefits when prescribing a statin for vascular indications, including in obese men, should not presently include prostate cancer risk.
AB - This commentary discusses the findings of Agalliu and colleagues, who performed a population-based, case-control study on the association between statin drugs and prostate cancer risk. Consistent with recent studies, statins were not associated with overall prostate cancer risk, but users had a possible lower risk of advanced disease. Obese men taking a statin had a higher risk of prostate cancer than those not taking a statin; however, a previously conducted, large, prospective, cohort study did not observe this association. This unexpected finding by Agalliu et al. could be a chance result, or could have arisen because of complex bias. Although statins might favorably affect men's prostate health, evidence is too limited to recommend statin use for the prevention of advanced prostate cancer. Consideration of the harms and benefits when prescribing a statin for vascular indications, including in obese men, should not presently include prostate cancer risk.
UR - http://www.scopus.com/inward/record.url?scp=60149083868&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=60149083868&partnerID=8YFLogxK
U2 - 10.1038/ncpuro1295
DO - 10.1038/ncpuro1295
M3 - Comment/debate
C2 - 19153570
AN - SCOPUS:60149083868
SN - 1743-4270
VL - 6
SP - 70
EP - 71
JO - Nature Clinical Practice Urology
JF - Nature Clinical Practice Urology
IS - 2
ER -